B lymphocyte depletion therapy with rituximab in rheumatoid arthritis

被引:71
作者
Edwards, JCW [1 ]
Leandro, MJ [1 ]
机构
[1] UCL, Ctr Rheumatol, London W1T 4NJ, England
关键词
D O I
10.1016/j.rdc.2004.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B lymphocyte depletion therapy in rheumatoid arthritis can provide major clinical benefits. Widespread use in the future will depend on continued evidence of safety, particularly in the context of long-term use. Rituximab is a highly effective agent, but it may be best used in combination with other agents. Substantial improvement following a single course of therapy has been found to last up to 42 months, and it is reasonable to hope that further development of strategies targeting B cells will extend this toward the original aim of truly long-term remission.
引用
收藏
页码:393 / +
页数:12
相关论文
共 26 条
[1]  
Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO
[2]  
2-G
[3]  
Bhatia A, 1998, IMMUNOLOGY, V94, P56
[4]   Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis [J].
Cambridge, G ;
Leandro, MJ ;
Edwards, JCW ;
Ehrenstein, MR ;
Salden, M ;
Bodman-Smith, M ;
Webster, ADB .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2146-2154
[5]  
CHANG YH, 1978, ARTHRITIS RHEUM, V21, P169
[6]   Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis - Evidence for a pathogenetic role of B cells [J].
De Vita, S ;
Zaja, F ;
Sacco, S ;
De Candia, A ;
Fanin, R ;
Ferraccioli, G .
ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :2029-2033
[7]   Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes [J].
Edwards, JCW ;
Cambridge, G .
RHEUMATOLOGY, 2001, 40 (02) :205-211
[8]  
Edwards JCW, 1999, IMMUNOLOGY, V97, P188
[9]  
Edwards JCW, 1998, BRIT J RHEUMATOL, V37, P126
[10]   IS RHEUMATOID-ARTHRITIS A FAILURE OF B-CELL DEATH IN SYNOVIUM [J].
EDWARDS, JCW ;
CAMBRIDGE, J .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (09) :696-700